T Vigander
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
-
- Neuroendocrine Tumor Research Advances
Papers in
-
- Pleural and Pulmonary Diseases 2
- Surgery 2
- Management of metastatic bone disease 1
- Gastrointestinal disorders and treatments 1
- Co-authors
- Sverre Langård (1 shared paper)Tor‐Erik Widerøe (1 shared paper)Ulf Aasebø (1 shared paper)Jan Vilsvik (1 shared paper)Reidulv Hatlevoll (1 shared paper)Ragnar Dahle (1 shared paper)Roy M. Bremnes (1 shared paper)Nils P. Boye (1 shared paper)
- Journals
- Journal of Clinical Oncology (1 paper)Cancer (1 paper)Occupational and Environmental Medicine (1 paper)PubMed (2 papers)BMJ (1 paper)
- Partner nations
- Norway
In The Last Decade
T Vigander
5 papers receiving 536 citations
Peers
Comparison fields: 5 of 74
- Oncology 333
- Epidemiology 166
- Health, Toxicology and Mutagenesis 63
- Pulmonary and Respiratory Medicine 122
- Psychiatry and Mental health 53
Countries citing papers authored by T Vigander
This map shows the geographic impact of T Vigander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Vigander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Vigander more than expected).
Fields of papers citing papers by T Vigander
This network shows the impact of papers produced by T Vigander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Vigander. The network helps show where T Vigander may publish in the future.
Co-authors
The 16 scholars most cited alongside T Vigander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 370 | |
| 2 | 1983 | 95 | |
| 3 | 1974 | 72 | |
| 4 | 1981 | 28 | |
| 5 | Characterization of pleural effusions by flow-cytometric DNA analysis. | 1985 | 11 |
| 6 | [Antibiotics in chronic bronchitis]. | 1980 | 1 |
About T Vigander
T Vigander is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Oncology, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine, having authored 6 papers that have together received 577 indexed citations. Recurring topics across this work include Pleural and Pulmonary Diseases (2 papers), Trigeminal Neuralgia and Treatments (1 paper), Lung Cancer Research Studies (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Management of metastatic bone disease (1 paper), Asthma and respiratory diseases (1 paper), Chemotherapy-induced cardiotoxicity and mitigation (1 paper) and Gastrointestinal disorders and treatments (1 paper). The work is most often cited by research in Oncology (333 citations), Epidemiology (166 citations), Health, Toxicology and Mutagenesis (63 citations), Pulmonary and Respiratory Medicine (122 citations) and Psychiatry and Mental health (53 citations). T Vigander has collaborated with scholars based in Norway. Frequent co-authors include Sverre Langård, Tor‐Erik Widerøe, Ulf Aasebø, Jan Vilsvik, Reidulv Hatlevoll, Ragnar Dahle, Roy M. Bremnes, Nils P. Boye, Einar Hannisdal and Eva Skovlund. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Occupational and Environmental Medicine, PubMed and BMJ.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.